Stock Scorecard



Stock Summary for NeuroOne Medical Technologies Corp (NMTC) - $1.15 as of 4/19/2024 8:38:48 PM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NMTC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NMTC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NMTC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for NMTC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for NMTC

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology 4/10/2024 1:00:00 PM
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes 4/9/2024 1:05:00 PM
InnovationRx: Base Editing Pioneer Nicole Gaudelli Joins GV 3/27/2024 9:58:00 PM
NeuroOnes's Innovative Electrode Brain Monitoring Seeks To Provide Insights Into Neurological Disorders - Zimmer Biomet Holdings ( NYSE:ZBH ) , NeuroOne Medical Tech ( NASDAQ:NMTC ) 3/27/2024 12:05:00 PM
NeuroOne® to Participate in the 36th Annual Roth Conference 3/8/2024 5:00:00 PM
NeuroOne Medical Technologies' ( NASDAQ: NMTC ) Innovative Brain Monitoring Tech Developing And Commercializing Electrodes To Provide Insights To Help Physicians Treat Neurological Disorders Like Epilepsy - NeuroOne Medical Tech ( NASDAQ:NMTC ) 3/7/2024 3:07:00 PM
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) 2/23/2024 10:10:00 PM
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 2/8/2024 8:30:00 PM
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update 12/14/2023 9:15:00 PM
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14 12/7/2023 9:30:00 PM

Financial Details for NMTC

Company Overview

Ticker NMTC
Company Name NeuroOne Medical Technologies Corp
Country USA
Description NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name PATENT OWNERS & LESSORS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 1.15
Last Day Price Updated 4/19/2024 8:38:48 PM EST
Last Day Volume 19,193
Average Daily Volume 237,564
52-Week High 2.00
52-Week Low 0.85
Last Price to 52 Week Low 35.29%

Valuation Measures

Trailing PE N/A
Industry PE 18.98
Sector PE 63.90
5-Year Average PE -4.03
Free Cash Flow Ratio 11.50
Industry Free Cash Flow Ratio 5.08
Sector Free Cash Flow Ratio 173.85
Current Ratio Most Recent Quarter 3.68
Total Cash Per Share 0.10
Book Value Per Share Most Recent Quarter 0.18
Price to Book Ratio 6.93
Industry Price to Book Ratio 2.76
Sector Price to Book Ratio 3.51
Price to Sales Ratio Twelve Trailing Months 10.87
Industry Price to Sales Ratio Twelve Trailing Months 6.40
Sector Price to Sales Ratio Twelve Trailing Months 3.44

Share Statistics

Total Shares Outstanding 25,930,900
Market Capitalization 29,820,535
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -18.60%
Reported EPS 12 Trailing Months -0.68
Reported EPS Past Year -0.14
Reported EPS Prior Year -0.65
Net Income Twelve Trailing Months -13,471,622
Net Income Past Year -11,859,491
Net Income Prior Year -9,999,613
Quarterly Revenue Growth YOY -37.70%
5-Year Revenue Growth 613.83%

Balance Sheet

Total Cash Most Recent Quarter 2,680,985
Total Cash Past Year 2,680,985
Total Cash Prior Year 5,322,493
Net Cash Position Most Recent Quarter 2,680,985
Net Cash Position Past Year 2,680,985
Long Term Debt Past Year 0
Long Term Debt Prior Year 1,007,206
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 4,418,156
Total Stockholder Equity Prior Year 6,249,404
Total Stockholder Equity Most Recent Quarter 4,418,156

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.01
MACD Signal 0.00
20-Day Bollinger Lower Band 0.90
20-Day Bollinger Middle Band 1.32
20-Day Bollinger Upper Band 1.74
Beta 1.06
RSI 46.09
50-Day SMA 1.23
200-Day SMA 2.88

System

Modified 4/18/2024 7:04:56 AM EST